To make provision about the evaluation of methods of testing the safety of medicines; and for connected purposes
The Bill proposes the establishment of a Medicines Safety Evaluation Panel to compare the effectiveness of human biology-based tests and animal-based tests in assessing the safety of medicines and drugs. The panel would be required to report within two years and would have full access to all relevant records held by the Medicines and Healthcare Products Regulatory Agency.
House of Commons
30 October 2008
The Safety of Medicines (Evaluation) Bill would create a Medicines Safety Evaluation Panel to compare how well tests based on human biology work compared with traditional animal tests for medicine safety. The panel must report its findings within two years and will have full access to relevant records held by the MHRA. The aim is to inform future approaches to evaluating medicine safety.
The bill is currently at the Second Reading in the House of Commons, having originated there. If it progresses, it would move to detailed scrutiny in committee.
Generated 21 February 2026
No recorded votes for this bill yet.
